61 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
(BSEP) protein.
LIVMARLI can cause side effects, including:
Liver injury. Changes in certain liver tests are common in patients with Alagille … syndrome and PFIC but can worsen during treatment. These changes may be a sign of liver injury. In PFIC, this can be serious or may lead to liver transplant
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
28 Feb 24
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:05pm
and can worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your healthcare provider should do blood
8-K
EX-99.1
dasv029gf4p 2hcy96
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
EX-99.2
3iqmii
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
EX-99.1
wc3yqkkbson8jjektdio
2 Nov 23
Results of Operations and Financial Condition
4:06pm
8-K
EX-99.1
qpqm9f9rqxn g7cyl7
13 Oct 23
Other Events
4:16pm
8-K
EX-10.1
xhz4u1tmornwg01l3hx0
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
wuxnhje21 rauh7l1
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-2.1
zo7h86ak0 ex
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
nmpo4g24y0winzot0 ta
4 May 23
Results of Operations and Financial Condition
4:02pm
8-K
EX-99.1
icwlo2qmdku
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
EX-99.1
ildvq
9 Nov 22
Results of Operations and Financial Condition
7:30am
8-K
EX-99.1
r10 20aljf02qj
24 Oct 22
Regulation FD Disclosure
8:46am